Positioning of Abraxane and Anti-PD-1 Antibodies Will Be Focus of Interest in Revised Guidelines for Gastric Cancer

The Japanese Gastric Cancer Association (JGCA) is revising the guidelines for the treatment of gastric cancer. Evidence from a number of clinical trials to be announced going forward is expected to be reflected in the revised guidelines’ recommendations on chemotherapy...read more